Cargando…

Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway

Osteoarthritis (OA), a degenerative joint disorder, has been reported as the most common cause of disability worldwide. The production of inflammatory cytokines is the main factor in OA. Previous studies have been reported that obeticholic acid (OCA) and OCA derivatives inhibited the release of proi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Dandan, He, Liming, Gao, Yaoxin, Jin, Chenxu, Lin, Haizhen, Zhang, Li, Wang, Liting, Zhou, Ying, Yao, Jie, Duan, Yixin, Yang, Renzheng, Qiu, Wenwei, Jiang, Wenzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067620/
https://www.ncbi.nlm.nih.gov/pubmed/33916928
http://dx.doi.org/10.3390/ijms22083807
_version_ 1783682846528897024
author Guo, Dandan
He, Liming
Gao, Yaoxin
Jin, Chenxu
Lin, Haizhen
Zhang, Li
Wang, Liting
Zhou, Ying
Yao, Jie
Duan, Yixin
Yang, Renzheng
Qiu, Wenwei
Jiang, Wenzheng
author_facet Guo, Dandan
He, Liming
Gao, Yaoxin
Jin, Chenxu
Lin, Haizhen
Zhang, Li
Wang, Liting
Zhou, Ying
Yao, Jie
Duan, Yixin
Yang, Renzheng
Qiu, Wenwei
Jiang, Wenzheng
author_sort Guo, Dandan
collection PubMed
description Osteoarthritis (OA), a degenerative joint disorder, has been reported as the most common cause of disability worldwide. The production of inflammatory cytokines is the main factor in OA. Previous studies have been reported that obeticholic acid (OCA) and OCA derivatives inhibited the release of proinflammatory cytokines in acute liver failure, but they have not been studied in the progression of OA. In our study, we screened our small synthetic library of OCA derivatives and found T-2054 had anti-inflammatory properties. Meanwhile, the proliferation of RAW 264.7 cells and ATDC5 cells were not affected by T-2054. T-2054 treatment significantly relieved the release of NO, as well as mRNA and protein expression levels of inflammatory cytokines (IL-6, IL-8 and TNF-α) in LPS-induced RAW 264.7 cells. Moreover, T-2054 promoted extracellular matrix (ECM) synthesis in TNF-α-treated ATDC5 chondrocytes. Moreover, T-2054 could relieve the infiltration of inflammatory cells and degeneration of the cartilage matrix and decrease the levels of serum IL-6, IL-8 and TNF-α in DMM-induced C57BL/6 mice models. At the same time, T-2054 showed no obvious toxicity to mice. Mechanistically, T-2054 decreased the extent of p-p65 expression in LPS-induced RAW 264.7 cells and TNF-α-treated ATDC5 chondrocytes. In summary, we showed for the first time that T-2054 effectively reduced the release of inflammatory mediators, as well as promoted extracellular matrix (ECM) synthesis via the NF-κB-signaling pathway. Our findings support the potential use of T-2054 as an effective therapeutic agent for the treatment of OA.
format Online
Article
Text
id pubmed-8067620
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80676202021-04-25 Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway Guo, Dandan He, Liming Gao, Yaoxin Jin, Chenxu Lin, Haizhen Zhang, Li Wang, Liting Zhou, Ying Yao, Jie Duan, Yixin Yang, Renzheng Qiu, Wenwei Jiang, Wenzheng Int J Mol Sci Article Osteoarthritis (OA), a degenerative joint disorder, has been reported as the most common cause of disability worldwide. The production of inflammatory cytokines is the main factor in OA. Previous studies have been reported that obeticholic acid (OCA) and OCA derivatives inhibited the release of proinflammatory cytokines in acute liver failure, but they have not been studied in the progression of OA. In our study, we screened our small synthetic library of OCA derivatives and found T-2054 had anti-inflammatory properties. Meanwhile, the proliferation of RAW 264.7 cells and ATDC5 cells were not affected by T-2054. T-2054 treatment significantly relieved the release of NO, as well as mRNA and protein expression levels of inflammatory cytokines (IL-6, IL-8 and TNF-α) in LPS-induced RAW 264.7 cells. Moreover, T-2054 promoted extracellular matrix (ECM) synthesis in TNF-α-treated ATDC5 chondrocytes. Moreover, T-2054 could relieve the infiltration of inflammatory cells and degeneration of the cartilage matrix and decrease the levels of serum IL-6, IL-8 and TNF-α in DMM-induced C57BL/6 mice models. At the same time, T-2054 showed no obvious toxicity to mice. Mechanistically, T-2054 decreased the extent of p-p65 expression in LPS-induced RAW 264.7 cells and TNF-α-treated ATDC5 chondrocytes. In summary, we showed for the first time that T-2054 effectively reduced the release of inflammatory mediators, as well as promoted extracellular matrix (ECM) synthesis via the NF-κB-signaling pathway. Our findings support the potential use of T-2054 as an effective therapeutic agent for the treatment of OA. MDPI 2021-04-07 /pmc/articles/PMC8067620/ /pubmed/33916928 http://dx.doi.org/10.3390/ijms22083807 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Guo, Dandan
He, Liming
Gao, Yaoxin
Jin, Chenxu
Lin, Haizhen
Zhang, Li
Wang, Liting
Zhou, Ying
Yao, Jie
Duan, Yixin
Yang, Renzheng
Qiu, Wenwei
Jiang, Wenzheng
Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway
title Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway
title_full Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway
title_fullStr Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway
title_full_unstemmed Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway
title_short Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway
title_sort obeticholic acid derivative, t-2054 suppresses osteoarthritis via inhibiting nf-κb-signaling pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067620/
https://www.ncbi.nlm.nih.gov/pubmed/33916928
http://dx.doi.org/10.3390/ijms22083807
work_keys_str_mv AT guodandan obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT heliming obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT gaoyaoxin obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT jinchenxu obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT linhaizhen obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT zhangli obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT wangliting obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT zhouying obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT yaojie obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT duanyixin obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT yangrenzheng obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT qiuwenwei obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway
AT jiangwenzheng obeticholicacidderivativet2054suppressesosteoarthritisviainhibitingnfkbsignalingpathway